Beranda › Leukemia Limfoblastik Akut › Ohio › Cincinnati
Uji klinis Leukemia Limfoblastik Akut di Cincinnati, OH
12 studi untuk Leukemia Limfoblastik Akut mencari peserta di lokasi sekitar Cincinnati (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- dan 3 lainnya
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Menerima pesertaFase 2
- Oncology Hematology Care, Cincinnati
- Cincinnati Children's Hospital Medical Center, Cincinnati
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Menerima pesertaFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Menerima pesertaFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Menerima pesertaFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Menerima pesertaStudi observasional
- Children's Hospital Medical Center, Cincinnati
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Menerima pesertaStudi observasional
- Cincinnati Children's Hospital, Cincinnati
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Menerima pesertaFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Menerima pesertaStudi observasional
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Menerima pesertaFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Menerima pesertaFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
Uji klinis Leukemia Limfoblastik Akut di kota lain
- Houston, TX28 studi
- New York City, NY24 studi
- Baldwin Park, CA21 studi
- Seattle, WA21 studi
- Chicago, IL19 studi
- Atlanta, GA19 studi
- Memphis, TN16 studi
- Philadelphia, PA16 studi
- Washington, DC16 studi
- Boston, MA15 studi
- Los Angeles, CA14 studi
- Durham, NC13 studi
Studi lain di Cincinnati
- Kanker Paru Non-Sel Kecil35 studi
- Kanker (semua jenis)27 studi
- Kanker Payudara25 studi
- Gagal Jantung24 studi
- Kanker Kolorektal21 studi
- Leukemia Mieloid Akut20 studi
- Kanker Metastatik20 studi
- Kanker Ovarium19 studi
- Kanker Paru19 studi
- Obesitas19 studi
- Kanker Prostat18 studi
- Mieloma Multipel17 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.